How children's muscles repair themselves and what that could mean for muscle disease
Official title: Understanding regulation of pediatric regenerative myogenesis and its implication for muscle disease
Funded at Children's Research Institute · NIH-11293415 · Data updated 2026-11-12
This project looks at why children's muscles heal so well and how that knowledge could help kids with early-onset muscle diseases like Duchenne muscular dystrophy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Children's Research Institute NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | April 1, 2025 |
| Project end | March 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $692,292 |
| NIH project number | 5R01NS136349-02 |
| Project ID | NIH-11293415 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates would be children with early-onset degenerative muscle diseases such as Duchenne muscular dystrophy, or families willing to provide tissue samples for research.
✕Less likely to help
Adults with age-related muscle loss or people with unrelated medical conditions are unlikely to see direct benefits from this pediatric-focused work.
What this research studies
From the patient's perspective, researchers are trying to understand why pediatric muscles regenerate faster and more completely than adult muscles by studying the cells and signals in the muscle environment. They will compare healthy pediatric muscle with dystrophic muscle to see which immune and support-cell interactions help or hinder repair. The team will use lab models and tissue-based experiments to identify points that could be targeted to boost regeneration. The goal is to find approaches that could eventually be turned into treatments to protect or improve muscle function in children with degenerative muscle diseases.
Why it matters
Potential benefit: If successful, this work could point to new therapies that help children's muscles regenerate better and slow the progression of diseases like Duchenne muscular dystrophy.
How similar studies have gone: Prior laboratory studies have improved muscle repair in models, but focusing on the pediatric muscle niche as a therapeutic target is a newer approach with limited direct clinical success so far.
Where this research is happening
-
Children's Research Institute
Washington, United States Active
Researchers
- Principal investigator: Novak, James Stephen — Children's Research Institute
- Study coordinator: Novak, James Stephen
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.